1. Akan H, Uzunkaya F, Soylu AI. Percutaneous ethanol sclerotherapy of venous malformations of the oral cavity and the oropharynx. Erciyes Med 2017;39:183-188.
3. Alexander MD, McTaggart RA, Choudhri OA, Pandit RP, Wu A, Ross M, et al. Quantitative volumetric analysis of head and neck venous and lymphatic malformations to assess response to percutaneous sclerotherapy. Acta Radiol 2016;57:205-209.
6. Bourgouin P, Thomas-Chaussé F, Gilbert P, Giroux MF, Périgny S, Guertin L, et al. Effectiveness and safety of sclerotherapy for treatment of low-flow vascular malformations of the oropharyngeal region. J Vasc Interv Radiol 2018;29:809-815.
8. Chen AW, Liu YR, Li K, Zhang K, Wang T, Liu SH. Efficacy of sclerotherapy with radio-opaque foam guided by digital subtraction angiography for the treatment of complex venous malformations of the head and neck. Br J Oral Maxillofac Surg 2015;53:809-813.
9. Chen WL, Huang ZQ, Zhang DM, Chai Q. Percutaneous sclerotherapy of massive venous malformations of the face and neck using fibrin glue combined with ok-432 and pingyangmycin. Head Neck 2010;32:467-472.
10. Chen Y, Li Y, Zhu Q, Zeng Q, Zhao J, He X, et al. Fluoroscopic intralesional injection with pingyangmycin lipiodol emulsion for the treatment of orbital venous malformations. AJR Am J Roentgenol 2008;190:966-971.
11. Choi YH, Han MH, O-Ki K, Cha SH, Chang KH. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate. J Vasc Interv Radiol 2002;13:475-482.
12. Colletti G, Deganello A, Bardazzi A, Mattassi R, Dalmonte P, Gazzabin L, et al. Complications after treatment of head and neck venous malformations with sodium tetradecyl sulfate foam. J Craniofac Surg 2017;28:e388-e392.
13. Costa JR, Torriani MA, Hosni ES, D’Avila OP, de Figueiredo PJ. Sclerotherapy for vascular malformations in the oral and maxillofacial region: treatment and follow-up of 66 lesions. J Oral Maxillofac Surg 2011;69:e88-e92.
14. Jia R, Xu S, Huang X, Song X, Pan H, Zhang L, et al. Pingyangmycin as first-line treatment for low-flow orbital or periorbital venous malformations: evaluation of 33 consecutive patients. JAMA Ophthalmol 2014;132:942-948.
15. Kim KH, Sung MW, Roh JL, Han MH. Sclerotherapy for congenital lesions in the head and neck. Otolaryngol Head Neck Surg 2004;131:307-316.
16. Kishi K, Morita N, Terada T, Sato M. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations. Phlebology 2014;29:276-286.
17. Lamba S, Keshava SKN, Moses V, Surendrababu N, Gupta AK. Ethanol sclerotherapy for treatment of venous malformations of face and neck—a single centre experience. Eur J Plast Surg 2012;35:345-350.
19. Li J, Chen J, Zheng G, Liao G, Fu Z, Li J, et al. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region. J Oral Maxillofac Surg 2010;68:2258-2266.
20. Liu Y, Liu D, Wang Y, Zhang W, Zhao F. Clinical study of sclerotherapy of maxillofacial venous malformation using absolute ethanol and pingyangmycin. J Oral Maxillofac Surg 2009;67:98-104.
21. Meng J, Zhuang QW, Gu QP, Zhang J, Li ZP, Si YM. Digital subtraction angiography (DSA) guided sequential sclerotherapy for maxillofacial vein malformation. Eur Rev Med Pharmacol Sci 2014;18:1709-1712.
23. Ribeiro MC, de Mattos Camargo Grossmann S, do Amaral MBF, de Castro WH, Navarro TP, Procopio RJ, et al. Effectiveness and safety of foam sclerotherapy with 5% ethanolamine oleate in the treatment of low-flow venous malformations in the head and neck region: a case series. Int J Oral Maxillofac Surg 2018;47:900-907.
24. Rosbe KW, Hess CP, Dowd CF, Frieden IJ. Masseteric venous malformations: diagnosis, treatment, and outcomes. Otolaryngol Head Neck Surg 2010;143:779-783.
26. Shigematsu T, Sorscher M, Dier EC, Berenstein A. Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy. J Neurointerv Surg 2019;11:57-61.
27. Siniluoto TM, Svendsen PA, Wikholm GM, Fogdestam I, Edström S. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol). Scand J Plast Reconstr Surg Hand Surg 1997;31:145-150.
28. Songsaeng D, Churojana A, Khumthong R, Mahiwan L. Comparative outcomes for sclerotherapy of head and neck venous vascular malformation between alcohol and bleomycin. J Med Assoc Thai 2015;98:408-413.
29. Spence J, Krings T, TerBrugge KG, Agid R. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy. Head Neck 2011;33:125-130.
31. Stimpson P, Hewitt R, Barnacle A, Roebuck DJ, Hartley B. Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children. Int J Pediatr Otorhinolaryngol 2012;76:569-573.
32. Su L, Fan X, Zheng L, Zheng J. Absolute ethanol sclerotherapy for venous malformations in the face and neck. J Oral Maxillofac Surg 2010;68:1622-1627.
33. Wang D, Su L, Han Y, Wang Z, Zheng L, Li J, et al. Direct intralesional ethanol sclerotherapy of extensive venous malformations with oropharyngeal involvement after a temporary tracheotomy in the head and neck: initial results. Head Neck 2017;39:288-296.
34. Wang YA, Zheng JW, Zhu HG, Ye WM, He Y, Zhang ZY. Sclerotherapy of voluminous venous malformation in head and neck with absolute ethanol under digital subtraction angiography guidance. Phlebology 2010;25:138-144.
35. Zhao JH, Zhang WF, Zhao YF. Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuate. Int J Oral Maxillofac Surg 2004;33:463-466.
36. Zheng JW, Yang XJ, Wang YA, He Y, Ye WM, Zhang ZY. Intralesional injection of pingyangmycin for vascular malformations in oral and maxillofacial regions: an evaluation of 297 consecutive patients. Oral Oncol 2009;45:872-876.
37. Zhi K, Wen Y, Li L, Ren W. The role of intralesional Pingyangmycin in the treatment of venous malformation of facial and maxillary region. Int J Pediatr Otorhinolaryngol 2008;72:593-597.
38. Luo QF, Gan YH. Pingyangmycin with triamcinolone acetonide effective for treatment of lymphatic malformations in the oral and maxillofacial region. J Craniomaxillofac Surg 2013;41:345-349.
39. Shiels WE 2nd, Kang DR, Murakami JW, Hogan MJ, Wiet GJ. Percutaneous treatment of lymphatic malformations. Otolaryngol Head Neck Surg 2009;141:219-224.
40. Tu JH, Do HM, Patel V, Yeom KW, Teng JMC. Sclerotherapy for lymphatic malformations of the head and neck in the pediatric population. J Neurointerv Surg 2017;9:1023-1026.
41. Flors L, Leiva-Salinas C, Maged IM, Norton PT, Matsumoto AH, Angle JF, et al. Mr imaging of soft-tissue vascular malformations: diagnosis, classification, and therapy follow-up. Radiographics 2011;31:1321-1340 ; discussion 1340-1341
42. Hage AN, Chick JFB, Srinivasa RN, Bundy JJ, Chauhan NR, Acord M, et al. Treatment of venous malformations: the data, where we are, and how it is done. Tech Vasc Interv Radiol 2018;21:45-54.
44. Yesil S, Tanyildiz HG, Bozkurt C, Cakmakci E, Sahin G. Single-center experience with sirolimus therapy for vascular malformations. Pediatr Hematol Oncol 2016;33:219-225.
45. Klosterman T, O TM. The management of vascular malformations of the airway: natural history, investigations, medical, surgical and radiological management. Otolaryngol Clin North Am 2018;51:213-223.